Literature DB >> 25463038

Drug discovery FAQs: workflows for answering multidomain drug discovery questions.

Christine Chichester1, Daniela Digles2, Ronald Siebes3, Antonis Loizou3, Paul Groth3, Lee Harland4.   

Abstract

Modern data-driven drug discovery requires integrated resources to support decision-making and enable new discoveries. The Open PHACTS Discovery Platform (http://dev.openphacts.org) was built to address this requirement by focusing on drug discovery questions that are of high priority to the pharmaceutical industry. Although complex, most of these frequently asked questions (FAQs) revolve around the combination of data concerning compounds, targets, pathways and diseases. Computational drug discovery using workflow tools and the integrated resources of Open PHACTS can deliver answers to most of these questions. Here, we report on a selection of workflows used for solving these use cases and discuss some of the research challenges. The workflows are accessible online from myExperiment (http://www.myexperiment.org) and are available for reuse by the scientific community.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Mesh:

Substances:

Year:  2014        PMID: 25463038     DOI: 10.1016/j.drudis.2014.11.006

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  7 in total

1.  A physiome interoperability roadmap for personalized drug development.

Authors:  Simon Thomas; Katherine Wolstencroft; Bernard de Bono; Peter J Hunter
Journal:  Interface Focus       Date:  2016-04-06       Impact factor: 3.906

Review 2.  Reporting biological assay screening results for maximum impact.

Authors:  Evan Bolton
Journal:  Drug Discov Today Technol       Date:  2015-05-02

Review 3.  Drug Design by Pharmacophore and Virtual Screening Approach.

Authors:  Deborah Giordano; Carmen Biancaniello; Maria Antonia Argenio; Angelo Facchiano
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-23

4.  Assessment of the significance of patent-derived information for the early identification of compound-target interaction hypotheses.

Authors:  Stefan Senger
Journal:  J Cheminform       Date:  2017-04-21       Impact factor: 5.514

5.  Explicit interaction information from WikiPathways in RDF facilitates drug discovery in the Open PHACTS Discovery Platform.

Authors:  Ryan A Miller; Peter Woollard; Egon L Willighagen; Daniela Digles; Martina Kutmon; Antonis Loizou; Andra Waagmeester; Stefan Senger; Chris T Evelo
Journal:  F1000Res       Date:  2018-01-17

Review 6.  Improving data workflow systems with cloud services and use of open data for bioinformatics research.

Authors:  Md Rezaul Karim; Audrey Michel; Achille Zappa; Pavel Baranov; Ratnesh Sahay; Dietrich Rebholz-Schuhmann
Journal:  Brief Bioinform       Date:  2018-09-28       Impact factor: 11.622

7.  Empowering pharmacoinformatics by linked life science data.

Authors:  Daria Goldmann; Barbara Zdrazil; Daniela Digles; Gerhard F Ecker
Journal:  J Comput Aided Mol Des       Date:  2016-11-09       Impact factor: 4.179

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.